Second Sight Medical Products Inc. (NASDAQ: EYES) Attends 31st Annual ROTH Conference
Second Sight Medical Products (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics intended to deliver useful artificial vision to blind individuals. A global leader in neuromodulation devices for blindness, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus® II Retinal Prosthesis System is the only FDA and CE Mark approved device for treating retinitis pigmentosa, with proven implant durability of multiple years. The company is developing the Orion® Visual Cortical Prosthesis which is intended to provide useful artificial vision to individuals who are blind due to various causes. For…







